CDC Choosing a Drug to Prevent Malaria CDC Malaria and Travelers October 2014 – Policies and actions for more effective malaria in pregnancy efforts (pdf) November 28, 2013 – Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation “In human clinical trials we have found that such
Stop AB499 STD Vaccines for Minor Children without Parental Consent “Why is AB499 So Dangerous? Even though you may make a conscientious informed decision to decline a vaccination for your child for a sexually transmitted disease like the controversial HPV Vaccine, AB499 permits a minor child 12 years old and
Stop AB499 STD Vaccines for Minor Children without Parental Consent “Why is AB499 So Dangerous? Even though you may make a conscientious informed decision to decline a vaccination for your child for a sexually transmitted disease like the controversial HPV Vaccine, AB499 permits a minor child 12 years old
MDCK cells are a line of canine (dog) epithelial cells that grow readily in culture and form confluent monolayers with relatively low permeability (varies between clones). Often used as a general model for epithelial cells. (Author: John Lackie for Dictionary of Cell and Molecular Biology – Online.) Madin-Darby canine kidney (MDCK)
STN: BL 125546 Proper Name: Meningococcal Group B Vaccine Trade Name: BEXSERO Manufacture: Novartis Vaccines and Diagnostics, Inc Indication: Active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Product Information Package Insert – BEXSERO Supporting Documents May 31, 2018 Approval Letter – BEXSERO October
August 28, 2018 – Emerging clinical experience with vaccines against group B meningococcal disease “While recent data from the United Kingdom supports the potential for protein-based vaccines to provide direct protection against MenB disease in immunised children, further research is required to understand the breadth and duration of this protection. A more detailed
Neisseria meningitidis, the bacteria that causes meningitis, has 13 clinically significant serogroups. These are classified according to the structure on the surface of their capsule. Six serogroups, A, B, C, Y, W135, and X are responsible for virtually all cases of the disease in humans. The most common cause of
Meningitis is inflammation of the meninges, the lining which surrounds the brain. The disease should not be confused with encephalitis which is inflammation of the brain itself. Essentially, there are two distinct types of meningitis; aseptic (usually caused by viral infections) and bacterial. Bacterial meningitis, while it is comparatively rare, is
Menomune (MPSV4) is a polysaccharide vaccine for serogroups A, C, Y and W-135 that has been available since 1970. The vaccine is approved for use in persons 2 years of age and older. The duration of immunity mediated by Menomune is three years or less in children aged under 5
Menveo, manufactured by Novartis, received approval for use in 2010 to vaccinate against Neisseria meningitidis serogroups A, C, Y and W-135. It is approved for use in people 11 to 55 years of age. Menveo Vaccine Package Insert Approval History, Letters, Reviews, and Related Documents – Menveo March 27, 2017